Search company, investor...
ConXtech company logo


Founded Year



Loan | Alive

Total Raised


Last Raised

$3.5M | 3 yrs ago

About ConXtech

ConXtech is a privately-held construction technology company based in Hayward, CA. The company has developed ConX, a mass-customizable, modular, prefabricated and sustainable structural steel building system. The system enables efficient delivery of robust and brace free structures for industrial, high-density residential, commercial, healthcare, data center and other applications. ConX is the first Cradle to Cradle Certified (CM) structural steel solution in the world. It reduces project schedule and installed cost compared to conventional structural options. The system enables all project stakeholders to predictably build Faster, Better, Safer and Greener.

Headquarters Location

6701 Koll Center Pkwy Suite 150

Pleasanton, California, 94566,

United States


Missing: ConXtech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ConXtech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ConXtech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ConXtech is included in 3 Expert Collections, including Construction Tech.


Construction Tech

843 items

Companies using technology to improve processes in the construction industry.


Smart Cities

3,282 items

Smart building tech covers energy management/HVAC tech, occupancy/security tech, connectivity/IoT tech, construction materials, robotics use in buildings, and the metaverse/virtual buildings.


Real Estate Tech

2,363 items

ConXtech Patents

ConXtech has filed 1 patent.

The 3 most popular patent topics include:

  • Structural system
  • Welding
  • Geodesy
patents chart

Application Date

Grant Date


Related Topics




Welding, Structural system, Architectural elements, Bridge components, Molecular biology


Application Date


Grant Date



Related Topics

Welding, Structural system, Architectural elements, Bridge components, Molecular biology



Latest ConXtech News

Kaiser ASC hits construction milestone

Oct 25, 2021

Patsy Newitt - Large Kaiser Permanente's " topped out " its new Murrieta (Calif.) Ambulatory Surgery Center, ConXtech, a construction company involved with the project, said Oct. 24. The 89,000-square-foot center is adjacent to an existing medical building and urgent care center, which currently provides outpatient services and primary care. The site expects to employ more than 3,000 people when it opens.

ConXtech Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ConXtech Rank

ConXtech Frequently Asked Questions (FAQ)

  • When was ConXtech founded?

    ConXtech was founded in 2004.

  • Where is ConXtech's headquarters?

    ConXtech's headquarters is located at 6701 Koll Center Pkwy, Pleasanton.

  • What is ConXtech's latest funding round?

    ConXtech's latest funding round is Loan.

  • How much did ConXtech raise?

    ConXtech raised a total of $72.12M.

  • Who are the investors of ConXtech?

    Investors of ConXtech include Paycheck Protection Program, Energy Innovation Capital, George Kaiser Family Foundation, Saudi Aramco Energy Ventures and Columbus Nova.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.